Artificial intelligence (AI) can provide solutions to many of the challenges facing the health care systems of the Islamic world. The use of AI technologies is expected to assist early diagnosis of chronic diseases, analysis of clinical data, patient monitoring and compliance. Most global healthcare companies are investing in AI strategies to discover new drugs for chronic and oncology diseases. It is estimated that the use of AI in pharma could generate $100B per annum in the USA only.
The Challenge:
How can AI be used to modernize Islamic world health care systems in one of the following pharmaceutical fields?
- New drug design and discovery,
- Patient data analysis and clinical trials
- Drug prescription and drug dosage optimization
- Remote patient monitoring
![](https://kans.mstfdn.org/wp-content/uploads/Assets/Partners-Logo-Images/Universiti Pendidikan Sultan Idris.png)
Universiti Pendidikan Sultan Idris (UPSI)
Malaysia